| P50 | author | Daniele Pezzati | Q64510204 |
| P2093 | author name string | Franco Filipponi | |
| | Davide Ghinolfi | |
| | Paolo De Simone | |
| | Emanuele Balzano | |
| P2860 | cites work | Transplantation for fulminant and subfulminant hepatic failure with preservation of portal and caval flow | Q71991735 |
| | Predictive factors of early postoperative graft function in human liver transplantation | Q72164890 |
| | A simple modification in operative technique can reduce the incidence of nonanastomotic biliary strictures after orthotopic liver transplantation | Q72371466 |
| | Timing of arterialization in liver transplantation | Q72854651 |
| | Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation | Q73823976 |
| | Warm preflush with streptokinase improves microvascular procurement and tissue integrity in liver graft retrieval from non-heart-beating donors | Q73832002 |
| | Split liver transplantation for two adult recipients: an initial experience | Q74415778 |
| | Successful transplantation of porcine livers after warm ischemic insult in situ and cold preservation including postconditioning with gaseous oxygen | Q74593329 |
| | Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia | Q78225710 |
| | The sequence of revascularization in liver transplantation: it does make a difference | Q79291137 |
| | Influence of degree of hepatic steatosis on graft function and postoperative complications of liver transplantation | Q79348719 |
| | Different methods of creatinine measurement significantly affect MELD scores | Q79832931 |
| | Using livers from donation after cardiac death donors--a proposal to protect the true Achilles heel | Q80109260 |
| | What lessons have we learned in pediatric liver transplantation? | Q81223848 |
| | The survival benefit of liver transplantation | Q81255000 |
| | Liver transplantation using suboptimal grafts: impact of donor harvesting technique | Q81366319 |
| | Extension of the adult hepatic allograft pool using split liver transplantation | Q81438569 |
| | The cumulative effects of cold ischemic time and older donor age on liver graft survival | Q81501151 |
| | Hepatic artery stenosis in liver transplant recipients: primary treatment with percutaneous transluminal angioplasty | Q81832417 |
| | Incidence, management, and results of vascular complications after liver transplantation | Q83841607 |
| | Safety and feasibility of diet-treated donors with steatotic livers at the initial consultation for living-donor liver transplantation | Q83864420 |
| | Multidrug donor preconditioning protects steatotic liver grafts against ischemia-reperfusion injury | Q84586582 |
| | Increased risk of graft loss from hepatic artery thrombosis after liver transplantation with older donors | Q84950889 |
| | The use of neoplastic donors to increase the donor pool | Q84969402 |
| | Hepatic artery pseudoaneurysms: a single-center experience | Q86859889 |
| | Advances in machine perfusion graft viability assessment in kidney, liver, pancreas, lung, and heart transplant | Q27003239 |
| | Strategies to rescue steatotic livers before transplantation in clinical and experimental studies | Q27003912 |
| | The model for end-stage liver disease (MELD) | Q28290440 |
| | A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients | Q28346817 |
| | Regional variability in symptom-based MELD exceptions: a response to organ shortage? | Q30454559 |
| | Importance of donor blood chemistry data (AST, serum sodium) in predicting liver transplant outcome. | Q33415227 |
| | Utilization of expanded criteria donors in liver transplantation | Q33871968 |
| | Using old liver grafts for liver transplantation: where are the limits? | Q34067836 |
| | Fatty liver in liver transplantation and surgery | Q34215124 |
| | Liver transplantation from non-heart-beating donors: current status and future prospects | Q34349436 |
| | Urgent revascularization of liver allografts after early hepatic artery thrombosis | Q34480368 |
| | Hepatic steatosis and its relationship to transplantation | Q34633676 |
| | Emerging concepts in liver graft preservation | Q34932318 |
| | The utility of marginal donors in liver transplantation | Q35163098 |
| | Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial | Q35681885 |
| | Subnormothermic machine perfusion for ex vivo preservation and recovery of the human liver for transplantation | Q35751559 |
| | Ischemia-Reperfusion Injury and Ischemic-Type Biliary Lesions following Liver Transplantation | Q35864132 |
| | Donor transmitted malignancies | Q35915516 |
| | Bile duct complications after liver transplantation | Q36135370 |
| | Age-related changes in liver structure and function: Implications for disease ? | Q36231400 |
| | Biliary complications after liver transplantation: a review | Q36510694 |
| | Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications | Q36617551 |
| | Histidine-tryptophan-ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: a systematic review | Q36897209 |
| | Management of portal venous complications after liver transplantation | Q37034664 |
| | The marginal liver donor--an update | Q37168618 |
| | Urokinase perfusion prevents intrahepatic ischemic-type biliary lesion in donor livers | Q37275738 |
| | Subnormothermic machine perfusion at both 20°C and 30°C recovers ischemic rat livers for successful transplantation | Q37392733 |
| | Steatosis reversibly increases hepatocyte sensitivity to hypoxia-reoxygenation injury. | Q37441570 |
| | Changing pattern of donor selection criteria in deceased donor liver transplant: a review of literature. | Q37613628 |
| | Late surgical complications following liver transplantation | Q37624628 |
| | Endovascular treatment of hepatic artery thrombosis following liver transplantation | Q37661652 |
| | Early outcomes of liver transplants in patients receiving organs from hypernatremic donors. | Q48108154 |
| | Outcomes of liver transplantations using donations after circulatory death: a single-center experience | Q48298509 |
| | In situ split liver transplantation for two adult recipients | Q49080226 |
| | The beneficial impact of temporary porto-caval shunt in orthotopic liver transplantation: a single center analysis. | Q50559767 |
| | Utility of pre-procurement bedside liver biopsy in the deceased extended-criteria liver donor. | Q50634655 |
| | The importance of portal venous blood flow in ischemic-type biliary lesions after liver transplantation. | Q51049368 |
| | The effect of age upon liver volume and apparent liver blood flow in healthy man. | Q53846028 |
| | Liver transplantation utilizing grafts from donors with genitourinary cancer detected prior to liver implantation | Q56782222 |
| | Impact of very advanced donor age on hepatic artery thrombosis after liver transplantation | Q56984772 |
| | Portal Vein Thrombosis in Liver Transplantation | Q58230776 |
| | Septuagenarian and Octogenarian Donors Provide Excellent Liver Grafts for Transplantation | Q60400337 |
| | DELAYED HEPATIC ARTERY THROMBOSIS IN ADULT ORTHOTOPIC LIVER TRANSPLANTATION???A 12-YEAR EXPERIENCE | Q61796756 |
| | Risk factors for primary dysfunction after liver transplantation--a multivariate analysis | Q70665180 |
| | The deleterious effect of donor high plasma sodium and extended preservation in liver transplantation. A multivariate analysis | Q71023212 |
| | Gastrointestinal and liver function of old age | Q71032820 |
| | Safe use of hepatic allografts from donors older than 70 years | Q71223594 |
| | Correlation between donor age and the pattern of liver graft recovery after transplantation | Q71544376 |
| | Impact of arterialization on hepatic oxygen supply, tissue energy phosphates, and outcome after liver transplantation in the rat | Q71588912 |
| | Machine perfusion of the liver: past, present and future. | Q37686018 |
| | Comparison of different immunoprophylaxis regimens after liver transplantation with hepatitis B core antibody-positive donors: a systematic review | Q37704264 |
| | Transmission of donor melanoma by organ transplantation | Q37745554 |
| | Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis | Q37842669 |
| | Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index. | Q37903388 |
| | Biliary complications after orthotopic liver transplantation: a review of incidence and risk factors | Q38030171 |
| | Donor-recipient matching: myths and realities | Q38056053 |
| | Use of octogenarian donors for liver transplantation: a survival analysis. | Q38259277 |
| | Donor liver histology--a valuable tool in graft selection | Q38391099 |
| | Alterations in the liver with ageing. | Q39839015 |
| | Solid organ transplantation from hepatitis B virus-positive donors: consensus guidelines for recipient management. | Q41468537 |
| | Donor hepatitis C sero-status does not impact survival in liver transplantation | Q41548363 |
| | The use of marginal donors for liver transplantation. A retrospective study of 365 liver donors | Q42132303 |
| | Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. | Q42623073 |
| | Deceased donors with a past history of malignancy: an organ procurement and transplantation network/united network for organ sharing update | Q42627678 |
| | Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation | Q42980541 |
| | Prediction of graft dysfunction based on extended criteria donors in the model for end-stage liver disease score era. | Q43004172 |
| | Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers | Q43034244 |
| | Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation | Q43289662 |
| | Stent placement versus angioplasty for hepatic artery stenosis after liver transplant: a meta-analysis of case series | Q43481319 |
| | Contribution of donor age to the recent decrease in patient survival among HCV-infected liver transplant recipients. | Q43519797 |
| | Fibrinolytic preflush upon liver retrieval from non-heart beating donors to enhance postpreservation viability and energetic recovery upon reperfusion | Q43675885 |
| | Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants | Q43752453 |
| | Temporary portocaval shunt during liver transplantation with vena cava preservation. Results of a prospective randomized study | Q43779253 |
| | Effect of ischemia-reperfusion injury on the microcirculation of the steatotic liver of the Zucker rat. | Q43811341 |
| | Does procurement technique affect posttransplant graft function in deceased donor liver transplantation? | Q44068668 |
| | The ageing liver | Q44096076 |
| | Influence of marginal donors on liver preservation injury | Q44157241 |
| | Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion | Q44347307 |
| | Heat-shock preconditioning protects fatty livers in genetically obese Zucker rats from microvascular perfusion failure after ischemia reperfusion | Q44405532 |
| | Arterial back table pressure perfusion prevents ischemic biliary lesions after orthotopic liver transplantation | Q44527779 |
| | Cancer transmission from organ donors-unavoidable but low risk | Q44628307 |
| | The delay of rearterialization after initial portal reperfusion in living donor liver transplantation significantly determines the development of microvascular graft dysfunction | Q45003251 |
| | Beneficial effects of tumor necrosis factor-alpha inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis | Q45077756 |
| | Liver transplantation with aged donors in patients with hepatitis C virus: authors' reply. | Q45343658 |
| | Long-term follow-up and outcome of liver transplantation from anti-hepatitis C virus-positive donors: a European multicentric case-control study. | Q45367497 |
| | Temporary intraoperative porto-caval shunt: useless or beneficial in piggy back liver transplantation? | Q45586276 |
| | Ischemic preconditioning (IP) of the liver as a safe and protective technique against ischemia/reperfusion injury (IRI). | Q45972837 |
| | A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic | Q46192627 |
| | Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation | Q46715480 |
| | Characteristics associated with liver graft failure: the concept of a donor risk index. | Q46734908 |
| | Back-table reconstruction of the donor replaced right hepatic artery prior to liver transplantation: what is the real impact on arterial complications? | Q46857391 |
| | Influence of flow and addition of oxygen during porcine liver hypothermic machine perfusion. | Q46937088 |
| | ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation | Q47335281 |
| | Hypothermic machine preservation in human liver transplantation: the first clinical series. | Q47582231 |
| | Hypothermic oxygenated perfusion (HOPE) protects from biliary injury in a rodent model of DCD liver transplantation | Q47627605 |
| | Conditioning With Sevoflurane in Liver Transplantation: Results of a Multicenter Randomized Controlled Trial | Q47736499 |
| | Compared efficacy of preservation solutions in liver transplantation: a long-term graft outcome study from the European Liver Transplant Registry. | Q47758493 |
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2636-2647 | |
| P577 | publication date | 2015-11-01 | |
| P1433 | published in | World Journal of Hepatology | Q27723328 |
| P1476 | title | Strategies to optimize the use of marginal donors in liver transplantation | |
| P478 | volume | 7 | |